EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV

Isaac Ngare iD, Toong Seng Tan, Mako Toyoda, Takeo Kuwata, Soichiro Takahama, Eriko Nakashima, Naoya Yamasaki, Chihiro Motozono, Teruhisa Fujii, Rumi Minami iD, Godfrey Barabona, Takamasa Ueno iD

Viruses · 2024

DOI: 10.3390/v16040555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Isaac Ngare und 11 weiteren Autor:innen. Beteiligte Einrichtung: Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, AMED Research Program on HIV/AIDS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People living with HIV (PLWH) could be at risk of blunted immune responses to COVID-19 vaccination. We investigated factors associated with neutralizing antibody (NAb) responses against SARS-CoV-2 and variants of concern (VOCs), following two-dose and third booster monovalent COVID-19 mRNA vaccination in Japanese PLWH. NAb titers were assessed in polyclonal IgG fractions by lentiviral-based pseudovirus assays. Overall, NAb titers against Wuhan, following two-dose vaccination, were assessed in 82 PLWH on treatment, whereby 17/82 (20.73%) were classified as low-NAb participants. Within the low-NAb participants, the third booster vaccination enhanced NAb titers against Wuhan and VOCs, albeit to a significantly lower magnitude than the rest. In the multivariate analysis, NAb titers against Wuhan after two-dose vaccination correlated with age and days since vaccination, but not with CD4+ count, CD4+/CD8+ ratio, and plasma high-sensitivity C-Reactive protein (hsCRP). Interestingly, an extended analysis within age subgroups revealed NAb titers to correlate positively with the CD4+ count and negatively with plasma hsCRP in younger, but not older, participants. In conclusion, a third booster vaccination substantially enhances NAb titers, but the benefit may be suboptimal in subpopulations of PLWH exhibiting low titers at baseline. Considering clinical and immune parameters could provide a nuanced understanding of factors associated with vaccine responses in PLWH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingAntibodies, ViralCOVID-19SARS-CoV-2HIV InfectionsImmunization, SecondaryCOVID-19 VaccinesEast Asian PeopleHumansMaleFemaleMiddle AgedAdultJapanAgedVaccinationCD4 Lymphocyte Count

Stichwörter der Autor:innen

COVID-19 vaccinationHIVSARS-CoV-2neutralizing antibodiesvariants of concern

Substanzen

Antibodies, NeutralizingAntibodies, ViralCOVID-19 Vaccines

Autor:innen und Institutionen

  • Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-8555, Japan.
  • Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan.
  • NHO, Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-8563, Japan.
  • Division of Transfusion Medicine, Hiroshima University Hospital, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
  • Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1, Sakuragaoka, Kagoshima 890-8544, Japan.

ORCID-Profile: Isaac Ngare, Rumi Minami, Takamasa Ueno

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • AMED Research Program on HIV/AIDS
  • AMED Research Program on Emerging and Re-Emerging Infectious Diseases
  • JSPS KAKENHI
  • Grant-in-Aid for Scientific Research
  • Japanese government (Monbukagakusho: MEXT) scholarship

Zitieren

APA

Ngare, I., Tan, T. S., Toyoda, M., Kuwata, T., Takahama, S., Nakashima, E., Yamasaki, N., Motozono, C., Fujii, T., Minami, R., Barabona, G., & Ueno, T. (2024). Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV. Viruses. https://doi.org/10.3390/v16040555

Vancouver

Ngare I, Tan TS, Toyoda M, Kuwata T, Takahama S, Nakashima E, et al. Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV. Viruses. 2024. doi:10.3390/v16040555

BibTeX
@article{Ngare2024,
  author = {Ngare, Isaac and Tan, Toong Seng and Toyoda, Mako and Kuwata, Takeo and Takahama, Soichiro and Nakashima, Eriko and Yamasaki, Naoya and Motozono, Chihiro and Fujii, Teruhisa and Minami, Rumi and Barabona, Godfrey and Ueno, Takamasa},
  title = {Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16040555}
}
Kostenlos starten →